InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Altimmune, Inc.

ALT Clue Score41
United States Fiscal year ends December CIK 0001326190
$2.61 +0.38% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.61 −78.92% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue3.2Operating income−11.1Net income−11.1EPS, diluted2.95Fiscal year 2017Revenue10.7 +231.8%Operating income−52.0Net income−46.4Fiscal year 2018Revenue10.3 −3.8%Operating income−42.8Net income−39.2Fiscal year 2019Revenue5.8 −43.8%Operating income−21.5Net income−20.5Fiscal year 2020Revenue8.2 +41.1%Operating income−54.8Net income−49.0EPS, diluted−1.91Fiscal year 2021Revenue4.4 −46.1%Operating income−96.9Net income−97.1EPS, diluted−2.35Fiscal year 2022Revenue−0.1 −101.5%Operating income−87.7Net income−84.7EPS, diluted−1.81Fiscal year 2023Revenue0.4Operating income−95.9Net income−88.4EPS, diluted−1.66Fiscal year 2024Revenue0.0 −95.3%Operating income−103.2Net income−95.1EPS, diluted−1.34Fiscal year 2025Revenue0.0 +105.0%Operating income−94.5Net income−88.1EPS, diluted−1.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 3.2 10.7 10.3 5.8 8.2 4.4 −0.1 0.4 0.0 0.0
Growth +231.8% −3.8% −43.8% +41.1% −46.1% −101.5% −95.3% +105.0%
Operating income −11.1 −52.0 −42.8 −21.5 −54.8 −96.9 −87.7 −95.9 −103.2 −94.5
Net income −11.1 −46.4 −39.2 −20.5 −49.0 −97.1 −84.7 −88.4 −95.1 −88.1
Growth
EPS, diluted 2.95 n/a n/a n/a −1.91 −2.35 −1.81 −1.66 −1.34 −1.00

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−342.7%Net margin−342.6%Free cash flow margin−200.2%Fiscal year 2017Operating margin−484.7%Net margin−432.3%Free cash flow margin−189.3%Fiscal year 2018Operating margin−414.6%Net margin−379.2%Free cash flow margin−100.3%Fiscal year 2019Operating margin−370.0%Net margin−353.7%Free cash flow margin−165.5%Fiscal year 2020Operating margin−669.5%Net margin−599.2%Free cash flow margin−421.6%Fiscal year 2021Operating margin−2,197.4%Net margin−2,201.4%Free cash flow margin−2,048.7%Fiscal year 2022Operating margin129,029.4%Net margin124,577.9%Free cash flow margin92,223.5%Fiscal year 2023Operating margin−22,518.5%Net margin−20,762.2%Free cash flow margin−17,806.8%Fiscal year 2024Operating margin−515,860.0%Net margin−475,295.0%Fiscal year 2025Operating margin−230,461.0%Net margin−214,861.0%Free cash flow margin−164,746.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −342.7% −484.7% −414.6% −370.0% −669.5% −2,197.4% 129,029.4% −22,518.5% −515,860.0% −230,461.0%
Net margin −342.6% −432.3% −379.2% −353.7% −599.2% −2,201.4% 124,577.9% −20,762.2% −475,295.0% −214,861.0%
Free cash flow margin −200.2% −189.3% −100.3% −165.5% −421.6% −2,048.7% 92,223.5% −17,806.8% n/a −164,746.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−6.4Capital expenditure−0.1Free cash flow−6.5Fiscal year 2017Operating cash flow−20.2Capital expenditure−0.1Free cash flow−20.3Fiscal year 2018Operating cash flow−9.4Capital expenditure−1.0Free cash flow−10.4Fiscal year 2019Operating cash flow−9.6Capital expenditure−0.0Free cash flow−9.6Fiscal year 2020Operating cash flow−34.3Capital expenditure−0.2Free cash flow−34.5Fiscal year 2021Operating cash flow−78.2Capital expenditure−12.1Free cash flow−90.4Fiscal year 2022Operating cash flow−62.6Capital expenditure−0.1Free cash flow−62.7Fiscal year 2023Operating cash flow−75.8Capital expenditure−0.0Free cash flow−75.9Fiscal year 2024Operating cash flow−79.8Fiscal year 2025Operating cash flow−67.5Capital expenditure−0.0Free cash flow−67.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −6.4 −20.2 −9.4 −9.6 −34.3 −78.2 −62.6 −75.8 −79.8 −67.5
Capital expenditure −0.1 −0.1 −1.0 −0.0 −0.2 −12.1 −0.1 −0.0 n/a −0.0
Free cash flow −6.5 −20.3 −10.4 −9.6 −34.5 −90.4 −62.7 −75.9 n/a −67.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash2.9Total debt0.5Net cash (debt)2.4Shareholders’ equity32.2Debt to equity0.02Fiscal year 2017Cash8.8Total debt0.6Net cash (debt)8.2Shareholders’ equity39.4Debt to equity0.02Fiscal year 2018Cash33.7Total debt1.9Net cash (debt)31.9Shareholders’ equity48.3Debt to equity0.04Fiscal year 2019Cash9.0Total debt1.9Net cash (debt)7.1Shareholders’ equity45.5Debt to equity0.04Fiscal year 2020Cash115.9Total debt1.8Net cash (debt)114.1Shareholders’ equity225.9Debt to equity0.01Fiscal year 2021Cash190.3Total debt1.5Net cash (debt)188.8Shareholders’ equity199.1Debt to equity0.01Fiscal year 2022Cash111.1Total debt4.6Net cash (debt)106.5Shareholders’ equity185.3Debt to equity0.02Fiscal year 2023Cash135.1Shareholders’ equity194.1Fiscal year 2024Cash36.9Shareholders’ equity123.5Fiscal year 2025Cash43.8Total debt34.3Net cash (debt)9.5Shareholders’ equity224.9Debt to equity0.15
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 2.9 8.8 33.7 9.0 115.9 190.3 111.1 135.1 36.9 43.8
Total debt 0.5 0.6 1.9 1.9 1.8 1.5 4.6 n/a n/a 34.3
Net cash (debt) 2.4 8.2 31.9 7.1 114.1 188.8 106.5 n/a n/a 9.5
Shareholders’ equity 32.2 39.4 48.3 45.5 225.9 199.1 185.3 194.1 123.5 224.9
Debt to equity 0.02 0.02 0.04 0.04 0.01 0.01 0.02 n/a n/a 0.15

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
3.2 10.7 10.3 5.8 8.2 4.4 −0.1 0.4 0.0 0.0
Growth +231.8% −3.8% −43.8% +41.1% −46.1% −101.5% −95.3% +105.0%
7.2 18.4 18.5 17.8 49.8 74.5 70.5 65.8 82.2 66.4
7.1 8.5 9.8 8.5 13.2 15.4 17.1 18.1 21.0 28.1
−11.1 −52.0 −42.8 −21.5 −54.8 −96.9 −87.7 −95.9 −103.2 −94.5
Growth
−11.1 −52.1 −45.3 −20.6 −54.5 −97.1 −84.9 −88.4 −95.1 −88.8
0.0 −5.6 −6.1 −0.1 −5.4 n/a −0.2 n/a n/a −0.7
−11.1 −46.4 −39.2 −20.5 −49.0 −97.1 −84.7 −88.4 −95.1 −88.1
Growth
Per share
2.97 n/a n/a n/a −1.91 −2.35 −1.81 −1.66 −1.34 −1.00
2.95 n/a n/a n/a −1.91 −2.35 −1.81 −1.66 −1.34 −1.00
Growth
65.3 n/a n/a n/a 25.6 41.3 46.9 53.2 71.0 88.1
65.7 n/a n/a n/a 25.6 41.3 46.9 53.2 71.0 88.1
Growth +61.0% +13.7% +13.5% +33.3% +24.1%

† The diluted share count jumps at 2020 and 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 65.3% a year over five years.
  • Operating margin is down 229,791.5 points on five years ago, at -230,461.0%.
  • A net loss in 10 of 10 years on file.